AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

There is a surge in diagnoses of low testosterone among men, driven by increased prescriptions, media, and online marketing. Experts warn this may lead to overdiagnosis of a ‘pseudo-disease,’ with potential health risks and societal impacts.

Health authorities and experts are raising concerns over the rising diagnosis and treatment of low testosterone in men, amid claims that a ‘pseudo-disease’ is being invented to sell hormone therapies. This trend has significant implications for men’s health and the medical community’s approach to hormonal health.

Recent data indicate a 135% increase in testosterone prescriptions in the UK between 2021 and 2024, with similar trends in the US. This surge coincides with the rise of direct-to-consumer men’s health companies like Voy, Hims, and Numan, which target men through social media marketing. Many men, such as Nick Dooley, report significant health improvements after testosterone replacement therapy (TRT), which is often initiated after brief blood tests and virtual consultations.

However, medical professionals, including NHS endocrinologist Channa Jayasena, warn that overdiagnosis may be occurring, with some men being diagnosed with low T despite having normal levels. The debate centers on whether low testosterone is underdiagnosed or if the current practices are pathologizing normal variations or minor issues. Experts note that testosterone levels naturally vary widely among men, making diagnosis complex, and that the medical community is struggling to manage the increasing demand without overprescribing.

Why It Matters

This trend matters because it reflects broader societal issues around masculinity, aging, and medicalization. Overdiagnosis can lead to unnecessary hormone treatments, which carry potential health risks such as cardiovascular problems or hormonal imbalances. It also raises questions about the influence of social media, celebrity endorsements, and marketing tactics in shaping men’s health perceptions and behaviors.

Amazon

men's testosterone test kit

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Background

The rise in testosterone prescriptions and diagnoses aligns with increased media coverage and online marketing promoting TRT as a solution to aging and low energy. Historically, testosterone therapy was reserved for men with diagnosed hypogonadism, but now many men are seeking treatment for symptoms like fatigue, depression, and weight gain, often without clear medical indications. This shift has prompted concern among healthcare providers about overmedicalization and the validity of some diagnoses, especially as companies exploit legal loopholes to advertise tests directly to consumers.

“We’re seeing more men diagnosed with low T, but the line between normal variation and deficiency is often blurred, leading to potential overdiagnosis.”

— Channa Jayasena, NHS endocrinologist

“Testosterone is vital for male development, but it’s also a hormone that can be misused or overprescribed, especially when driven by social trends.”

— Geoff Hackett, urologist

Amazon

testosterone replacement therapy supplements

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

What Remains Unclear

It remains unclear how widespread overdiagnosis truly is and whether most men receiving TRT are genuinely hormone-deficient. The long-term health impacts of increased hormone therapy use in men without clear hypogonadism are still being studied, and regulatory responses are evolving.

Amazon

natural testosterone booster supplements

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

What’s Next

Healthcare authorities and professional bodies are expected to review diagnostic criteria and advertising regulations for testosterone and related tests. Further research will clarify the health risks and benefits of TRT in men with borderline or normal testosterone levels. Public health campaigns may also emerge to educate men about hormonal health and avoid unnecessary treatments.

Amazon

men's hormone health monitor

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

Are men being overdiagnosed with low testosterone?

The evidence suggests a rise in diagnoses, but whether this reflects overdiagnosis or genuine deficiency remains debated among experts. Caution is advised in interpreting symptoms and test results.

What are the risks of testosterone replacement therapy?

Potential risks include cardiovascular issues, hormonal imbalances, and prostate health concerns. Long-term effects of TRT in men without clear deficiency are still under study.

Why is there a surge in testosterone prescriptions now?

The increase correlates with social media marketing, celebrity endorsements, and the availability of direct-to-consumer testing and treatments, which have normalized and popularized TRT among men.

Is low testosterone a normal part of aging?

Testosterone levels naturally decline with age, but the extent and clinical significance vary. Not all declines require treatment, and diagnosis should be based on comprehensive evaluation.

HALLOWEEN

Halloween Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Indoor Air and Sinus Pressure: The Overlooked Link

An overlooked connection between indoor air quality and sinus pressure may surprise you, but understanding it could lead to lasting relief.

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause

Lilly’s Foundayo, an oral GLP-1 medication, is confirmed to be taken without food or water restrictions, showing significant weight loss in women at menopause.

Sick Building Syndrome: Real or Overhyped?

Peel back the layers of Sick Building Syndrome to uncover whether it’s a genuine health concern or just a misconception; the truth may surprise you.

7 Books To Help You Cope With Failure And Move Forward

Discover seven influential books that provide guidance and strategies for coping with failure and building resilience for future success.